Drug intelligence / Profile preview

tragopogon coelesyriacus extract

Development stage
Preclinical
Administration
Oral
01

Overview

Tragopogon coelesyriacus extract is a botanical research compound derived from the aerial parts (stems, leaves, and flowers) of the biennial herbaceous plant *Tragopogon coelesyriacus* Boiss., a member of the Asteraceae family. The plant is traditionally consumed as a vegetable in Turkey. Preclinical studies, including in vitro and in silico analyses, have identified the extract as a source of bioactive phytochemicals, notably keracyanin chloride and naringin. These constituents have demonstrated potential antimicrobial activity against pathogens such as *Staphylococcus aureus*, *Pseudomonas aeruginosa*, and *Klebsiella pneumoniae*, as well as selective anticarcinogenic effects against AR42J pancreatic cancer cells. Mechanistically, keracyanin chloride is suggested to inhibit the bacterial cell wall biosynthesis enzyme MurB, while naringin targets FYN kinase, a protein involved in pancreatic cancer progression. The extract is currently in the early preclinical research phase and has not been developed into a commercial pharmaceutical product.

Other names
Tragopogon coelesyriacus extractmethanolic extract of Tragopogon coelesyriacuswater extract of Tragopogon coelesyriacus
02

Targets

MurB (UDP-N-acetylenolpyruvoylglucosamine reductase)FYN (Proto-oncogene tyrosine-protein kinase Fyn)

Beyond the preview

Go deeper on tragopogon coelesyriacus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tragopogon coelesyriacus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call